Herzog S, Cunze T, Martin M, Osmers R, Gleiter C, Kuhn W
Dept. Obstet. Gynaecol., Georg-August-Universität, Göttingen, Germany.
Eur J Obstet Gynecol Reprod Biol. 1999 Aug;85(2):199-204. doi: 10.1016/s0301-2115(99)00030-5.
Bolus tocolysis has been developed to reduce the dose of fenoterol compared to continuous tocolysis. Whereas the high efficacy of pulsatile application of fenoterol has been shown, the proof of reduced side effects is still lacking. A total of 59 patients with preterm labor were divided in three groups: (1) continuous tocolysis and oral application of magnesium (n=19), (2) continuous tocolysis and parenteral application of magnesium (n=20), (3) pulsatile tocolysis (bolus tocolysis) and oral application of magnesium (n=20). Heart rate, systolic and diastolic blood pressure, serum K+ and serum Mg++ were quantified before tocolysis and after 2, 8 and 24 h. Beta-blockers and water balance were recorded over 24 h. Subjective side effects were quantified using a questionnaire with scales graduated covering palpitations, tremor, diaphoresis, thirst, precardialgia and nausea/vomiting. The analysis of the data revealed significantly fewer side effects concerning heart rate, plasma K+ level and the subjective side effects among patients treated with bolus tocolysis than among those treated with continuous tocolysis. Between the latter two groups, no significant difference was found. Concerning blood pressure and need for beta-blockers, no significant differences were found between the three groups. The results of the present study show that especially the side effects subjectively found to be disagreeable by the patients are reduced by pulsatile tocolysis, whereas other side effects show only slight differences between the study groups.
与持续性宫缩抑制相比,推注宫缩抑制疗法已被研发用于减少非诺特罗的剂量。尽管已证实非诺特罗脉冲式给药具有高效性,但仍缺乏其副作用减少的证据。共有59例早产患者被分为三组:(1)持续性宫缩抑制并口服镁剂(n = 19),(2)持续性宫缩抑制并胃肠外应用镁剂(n = 20),(3)脉冲式宫缩抑制(推注宫缩抑制)并口服镁剂(n = 20)。在宫缩抑制治疗前以及治疗后2小时、8小时和24小时对心率、收缩压和舒张压、血清钾离子和血清镁离子进行定量分析。记录24小时内β受体阻滞剂的使用情况和水平衡情况。使用涵盖心悸、震颤、出汗、口渴、心前区疼痛和恶心/呕吐的量表问卷对主观副作用进行量化。数据分析显示,与接受持续性宫缩抑制治疗的患者相比,接受推注宫缩抑制治疗的患者在心率、血浆钾离子水平和主观副作用方面的副作用明显较少。在后两组之间未发现显著差异。在三组之间,关于血压和β受体阻滞剂的使用需求未发现显著差异。本研究结果表明,尤其是患者主观上认为令人不适的副作用可通过脉冲式宫缩抑制减少,而其他副作用在各研究组之间仅显示出轻微差异。